Journal of Cancer 2023

5 papers
The 2023 edition of the Journal of Cancer emphasized molecular mechanisms of tumor progression and the refinement of therapeutic strategies. Research themes centered on epitranscriptomic switches for mRNA stability, the transcriptional regulation of non-coding RNA feedback loops, and the reprogramming of hepatic lipid metabolism. Significant attention was given to precision delivery of molecular regulators and adaptive titration in treatment regimes. Genetic research focused on functional mapping of risk through quantitative trait loci and the identification of variants in the NRF2 signaling pathway associated with HBV-related hepatocellular carcinoma survival. Notable studies investigated the role of CircREOS in suppressing osteosarcoma progression by inhibiting MYC activation and the influence of SIK1 on colorectal cancer metastasis via the TGF-β pathway. Other research explored radiosensitization using PARP inhibitors like Olaparib and evaluated combined therapies for localized prostate adenocarcinoma. The year’s contributions, featuring authors such as Cheng He, Feng Yang, and Jiangbo Nie, also addressed technical improvements in medical imaging to reduce operator dependency and the functional validation of candidate genes in transcriptomic research.

Top Research Directions

The 16 research directions with Journal of Cancer 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Principles of Protein Expression Analysis via Western Blotting2040.0%0.0%—
2Bridging Genetic Associations and Biology with Molecular QTLs1020.0%0.0%—
3Cis Regulatory Control of Host Genes by Circular RNAs1020.0%0.0%—
4Engineering Precision Vehicles for Targeted RNA Delivery1020.0%0.0%—
5Flow Cytometric Analysis of Cell Cycle Distribution1020.0%0.0%—
6Hyperactive DNA Repair Pathways Drive Therapeutic Evasion1020.0%0.0%—
7Inducing Synthetic Lethality by Targeting DNA Repair1020.0%0.0%—
8Molecular Cascades Driving Cancer Metastasis1020.0%0.0%—
9Physiological Validation of Reductionist Molecular Mechanisms1020.0%0.0%—
10Predicting Complex Phenotypes via Polygenic Risk Aggregation1020.0%0.0%—
11Quantifying Cellular Motility and Invasion In Vitro1020.0%0.0%—
12Quantifying Single Cell DNA Damage and Repair Dynamics1020.0%0.0%—
13Reversing the Mesenchymal Phenotype to Suppress Metastasis1020.0%0.0%—
14The Discovery Replication Framework in Genetic Association Studies1020.0%0.0%—
15The In Vitro to In Vivo Validation Gap1020.0%0.0%—
16Validating Physical Protein Interactions via Co-Immunoprecipitation1020.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Cancer 2023 papers: a paper credits every institution named in its affiliations, once. 13 institutions share 5 credited papers.

#InstitutionPapersShare20222022 rank
101gb3y148 120.0%0—
202hx18343 120.0%0—
303dveyr97 120.0%0—
405gbwr869 120.0%0—
5Chengdu University 120.0%0—
6Chinese Academy of Sciences 120.0%0—
7Guangdong Provincial People's Hospital 120.0%0—
8Institute of Modern Physics 120.0%0—
9Lanzhou University 120.0%0—
10Nanchang University 120.0%0—
11South China University of Technology 120.0%0—
12Southern Medical University 120.0%15
13University of Chinese Academy of Sciences 120.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Cancer 2023 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 4 to 5 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 5 of 5 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Cancer 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-cancer/2023.

Impactful Papers

Papers from Journal of Cancer 2023 that shaped research clusters.

Influential

Papers

Title
CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation
Palliative TURP Combined with Intermittent ADT Is A Curative Therapy to Some Elderly Men with Localized Prostate Adenocarcinoma
Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival
Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions
SIK1 suppresses colorectal cancer metastasis and chemoresistance via the TGF-β signaling pathway